InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| ATP | The fungal peptide toxin Candidalysin activates the NLRP3 inflammasome and ca... | 2018 | Nat Commun. | Kasper L. et al. | DOI: 10.1038/s41467-018-06607-1 |
| ODN 1668 - TLR9 ligand | GM-CSF Culture Revisited: Preparation of Bulk Populations of Highly Pure Dend... | 2018 | J Immunol. | Jin D. & Sprent J. | DOI: 10.4049/jimmunol.1800031 |
| Nigericin | POH1 deubiquitinates pro-interleukin-1β and restricts inflammasome activity. | 2018 | Nat Commun. | Zhang L. et al. | DOI: 10.1038/s41467-018-06455-z |
| THP1-Dual™ KO-STING Cells | Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumo... | 2018 | Immunity. | Marcus A. et al. | DOI: 10.1016/j.immuni.2018.09.016 |
| VACV-70 | Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumo... | 2018 | Immunity. | Marcus A. et al. | DOI: 10.1016/j.immuni.2018.09.016 |
| THP1-Dual™ Cells | Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumo... | 2018 | Immunity. | Marcus A. et al. | DOI: 10.1016/j.immuni.2018.09.016 |
| ISD | Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumo... | 2018 | Immunity. | Marcus A. et al. | DOI: 10.1016/j.immuni.2018.09.016 |
| Quil-A® adjuvant | A malaria vaccine adjuvant based on recombinant antigen binding to liposomes. | 2018 | Nat Nanotechnol. | Huang W.C. et al. | DOI: 10.1038/s41565-018-0271-3 |
| Adju-Phos® adjuvant | A malaria vaccine adjuvant based on recombinant antigen binding to liposomes. | 2018 | Nat Nanotechnol. | Huang W.C. et al. | DOI: 10.1038/s41565-018-0271-3 |
| Blasticidin | Primate immunodeficiency virus proteins Vpx and Vpr counteract transcriptiona... | 2018 | Nat Microbiol. | Yurkovetskiy L. et al. | DOI: 10.1038/s41564-018-0256-x |
| Poly(I:C) HMW | Intestinal Dysmotility Syndromes following Systemic Infection by Flaviviruses. | 2018 | Cell. | White J.P. et al. | DOI: 10.1016/j.cell.2018.08.069 |
| NLRP3 inflammasome inhibitor - MCC950 | Porphyromonas gingivalis triggers NLRP3-mediated inflammasome activation in m... | 2018 | Eur J Immunol. | Okano T. et al. | DOI: 10.1002/eji.201847658 |
| CL264 | Dual TLR2 and TLR7 agonists as HIV latency-reversing agents. | 2018 | JCI Insight. | Macedo A.B. et al. | DOI: 10.1172/jci.insight.122673 |
| Pam2CSK4 | Dual TLR2 and TLR7 agonists as HIV latency-reversing agents. | 2018 | JCI Insight. | Macedo A.B. et al. | DOI: 10.1172/jci.insight.122673 |
| TDB | Dual route vaccination for plague with emergency use applications. | 2018 | Vaccine. | Moore B.D. et al. | DOI: 10.1016/j.vaccine.2018.06.039 |
| TDB VacciGrade™ | Dual route vaccination for plague with emergency use applications. | 2018 | Vaccine | Moore B.D. et al. | DOI: 10.1016/j.vaccine.2018.06.039 |
| CpG-free Luc::Sh | Nanoparticle uptake by circulating leukocytes: A major barrier to tumor deliv... | 2018 | J Control Release. | Betker J.L. et al. | DOI: 10.1016/j.jconrel.2018.07.031 |
| Adilipoline™ (CL413) | Dual TLR2 and TLR7 agonists as HIV latency-reversing agents. | 2018 | JCI Insight. | Macedo A.B. et al. | DOI: 10.1172/jci.insight.122673 |
| STAT3 | Interaction of STAT3 and RelB modulates MMP-1 in colon cancer. | 2018 | Chem Biol Interact. | Jiang X.F. et al. | DOI: 10.1016/j.cbi.2018.07.017 |
| TL8-506 | Toll-like receptor agonist R848 blocks Zika virus replication by inducing the... | 2018 | Virology. | Vanwalscappel B. et al. | DOI: 10.1016/j.virol.2018.07.014 |